Raritan Recalls CVS Kids' Ear Relief Liquid for Manufacturing Deviations
Raritan Pharmaceuticals is voluntarily recalling 20,448 bottles of CVS pharmacy Kids' Ear Relief Oral Liquid due to Current Good Manufacturing Practice (CGMP) deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to CGMP deviations, which typically corresponds to a moderate risk of temporary or medically reversible adverse health consequences.
Plain-English summary
Raritan Pharmaceuticals, Inc. is voluntarily recalling 20,448 bottles of CVS pharmacy Kids' Ear Relief Oral Liquid, 0.85 oz (25 mL). The product is distributed by CVS Pharmacy, Inc. and carries the NDC 59779-687-02 and UPC 77815909639. The specific lot affected is # 33149 with an expiration date of 01/20.
The recall was initiated because of Current Good Manufacturing Practice (CGMP) deviations. The FDA has classified this recall as Class II, which indicates that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
The affected product was distributed in New York. Consumers who have this product should stop using it and contact CVS Pharmacy or Raritan Pharmaceuticals for further instructions or a refund.
The recalled product
- Product
- CVS pharmacy Kids' Ear Relief Oral Liquid 0.85 oz (25 mL) Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket RI 02895 NDC 59779-687-02 UPC 77815909639
- Manufacturer
- Raritan Pharmaceuticals, Inc.
- Category
- Drug — OTC Ear Drops
- Hazard
- Affected units
- 20,448
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 33149
- Exp. 01/20
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 3 recalled by Raritan Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Raritan Pharmaceuticals, Inc.
See all →- ModerateRaritan Recalls Kids' Relief Ear Liquid Due to Manufacturing Deviations
FDA (Drugs) · 2017-01-04
- ModerateCVS Health Homeopathic Infants Teething Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2017-01-04
- SevereRaritan Recalls Up&Up Psyllium Fiber Supplement for C. Difficile Contamination
FDA (Drugs) · 2012-10-31
- SevereEquate Fiber Therapy Recalled for Possible C. Difficile Contamination
FDA (Drugs) · 2012-10-31
- SevereRaritan Recalls Leader Fiber Capsules Due to C. Difficile Contamination
FDA (Drugs) · 2012-10-31
Same hazard · cgmp deviations
See all →- ModerateFentanyl Citrate Injectable Solution Recall Due to cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateGlenmark Pharmaceuticals Recalls Pravastatin Sodium Tablets 80mg
FDA (Drugs) · 2025-04-16
- ModerateGlenmark Lacosamide 100mg Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-16
- ModerateDrug Recall: APAP 500 mg Phenyl HCl Tablets for CGMP Deviations
FDA (Drugs) · 2022-02-16
- ModerateMigrenol Caplet Drug Recalled for CGMP Deviations
FDA (Drugs) · 2022-02-16